On 18 Dec 2019, Kura Oncology, Inc. (NASDAQ: KURA) stock observed trading -35.29% off 52-week high price. On the other end, the stock has been noted 12.68% away from low price over the last 52-weeks. The stock disclosed a move of -7.19% away from 50 day moving average and -15.60% away from 200 day moving average. Moving closer, we can see that shares have been trading -9.17% off 20-day moving average.
Kura Oncology, Inc. (KURA) recently stated third quarter 2019 financial results and provided a corporate update.
Research and development expenses for the third quarter of 2019 were $12.5M, contrast to $11.7M for the third quarter of 2018.
General and administrative expenses for the third quarter of 2019 were $5.1M, contrast to $4.3M for the third quarter of 2018.
Net loss for the third quarter of 2019 was $16.4M, or $0.36 per share, contrast to $15.0M, or $0.40 per share, for the third quarter of 2018.
Cash, cash equivalents and short-term investments totaled $250.1M as of September 30, 2019, contrast with $179.0M as of December 31, 2018.
Management continues to expect that current cash, cash equivalents and short-term investments will be sufficient to fund current operations into the second half of 2021.
The USA based company Kura Oncology, Inc. moved with change of -4.68% to $13.86 with the total traded volume of 289186 shares in recent session versus to an average volume of 280.52K. KURA’s shares are at -15.69% for the quarter and driving a -0.29% return over the course of the past year and is now at -1.28% since this point in 2018. Right now, the stock beta is 2.57. The average volatility for the week and month was at 4.43% and 4.36% respectively. There are 45.53M shares outstanding and 38.24M shares are floated in market.